Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data

A Comparison of Alternative Econometric Cost Modeling Techniques

Datos Bibliográficos

ID9103643
AutoresChristopher A Powers (Maryland Dermatology Laser Skin and Vein Institute), Christina Meyer (0000-0003-1270-9968, Maryland Dermatology Laser Skin and Vein Institute), Christina M Meyer, M Christopher Roebuck (0000-0003-4102-4925, Maryland Dermatology Laser Skin and Vein Institute), Baze Vaziri (Maryland Dermatology Laser Skin and Vein Institute)
Año2005
Volumen43
Número11
Páginas1065-1072
Fecha de publicación2005-11-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaMedical Care (JOURNAL)
Identificadores de la revistaISSN: 0025-7079 • E-ISSN: 1537-1948
EditorialOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/01.mlr.0000182408.54390.00
PMID16224298
OpenAlexW2063820885
IdiomaEN
Citas recibidas4
Referencias citadas24

OBJECTIVE: We sought to evaluate several statistical modeling approaches in predicting prospective total annual health costs (medical plus pharmacy) of health plan participants using Pharmacy Health Dimensions (PHD), a pharmacy claims-based risk index. METHODS: We undertook a 2-year (baseline year/follow-up year) longitudinal analysis of integrated medical and pharmacy claims. Included were plan participants younger than 65 years of age with continuous medical and pharmacy coverage (n = 344,832). PHD drug categories, age, gender, and pharmacy costs were derived across the baseline year. Annual total health costs were calculated for each plan participant in follow-up year. Models examined included ordinary least squares (OLS) regression, log-transformed OLS regression with smearing estimator, and 3 two-part models using OLS regression, log-OLS regression with smearing estimator, and generalized linear modeling (GLM), respectively. A 10% random sample was withheld for model validation, which was assessed via adjusted r, mean absolute prediction error, specificity, and positive predictive value. RESULTS: Most PHD drug categories were significant independent predictors of total costs. Among models tested, the OLS model had the lowest mean absolute prediction error and highest adjusted r. The log-OLS and 2-part log-OLS models did not predict costs accurately as the result of issues of log-scale heteroscedasticity. The 2-part model using GLM had lower adjusted r but similar performance in other assessment measures compared with the OLS or 2-part OLS models. CONCLUSION: The PHD system derived solely from pharmacy claims data can be used to predict future total health costs. Using PHD with a simple OLS model may provide similar predictive accuracy in comparison to more advanced econometric models

Econometrics · Economics · Family medicine · Health care · Heteroscedasticity · Linear regression · Ordinary least squares · Predictive modelling · Regression analysis · Statistics · Chronic Disease Management Strategies · Demography · Health Systems, Economic Evaluations, Quality of Life · Mathematics · Medication Adherence and Compliance · Medicine · Pharmacy

  • Risk Adjustment for Health Care Financing in Chronic Disease

    Theodore A Omachi, Steven E Gregorich et al.•Medical Care•2013

  • Predicting Healthcare Utilization Using a Pharmacy-based Metric With the WHO’s Anatomic Therapeutic Chemical Algorithm

    Raymond N Kuo, Yaa-Hui Dong et al.•Medical Care•2011

  • Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients

    Julie C Lauffenburger, Jessica M Franklin et al.•Medical Care•2017

  • Mothers of Children Diagnosed With Attention-Deficit/Hyperactivity Disorder

    G Thomas Ray, Lisa A Croen et al.•Medical Care•2009

  • A Simple Test for Heteroscedasticity and Random Coefficient Variation

    Trevor Breusch, T S Breusch et al.•Econometrica•1979

  • Diagnostics for heteroscedasticity in regression

    R Dennis Cook, Sanford Weisberg•Biometrika•1983

  • Smearing Estimate

    Naihua Duan•Journal of the American…•1983

  • Much ado about two

    Open Access•John Mullahy•Journal of Health Economics•1998

  • Too much ado about two-part models and transformation?

    Open Access•Melinda Beeuwkes Buntin, Alan M Zaslavsky•Journal of Health Economics•2004

  • Estimating log models

    Open Access•Willard G Manning, John Mullahy•Journal of Health Economics•2001

  • The logged dependent variable, heteroscedasticity, and the retransformation problem

    Open Access•Willard G Manning•Journal of Health Economics•1998

  • Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population

    Anne E Sales, Chuan-Fen Liu et al.•Medical Care•2003

  • Construction and Characteristics of the RxRisk-V

    Kevin L Sloan, Anne E Sales et al.•Medical Care•2003

  • Improving Risk Adjustment for Medicare Capitated Reimbursement Using Nonlinear Models

    Peter J Veazie, Willard G Manning et al.•Medical Care•2003

  • Development and Estimation of a Pediatric Chronic Disease Score Using Automated Pharmacy Data

    Paul Fishman, Paul A Fishman et al.•Medical Care•1999

  • The Medicaid Rx Model

    Todd Gilmer, Richard Kronick et al.•Medical Care•2001

  • Risk Adjustment Using Automated Ambulatory Pharmacy Data

    Paul Fishman, Paul A Fishman et al.•Medical Care•2003

  • A Chronic Disease Score with Empirically Derived Weights

    Daniel O Clark, MICHAEL VON KORFF et al.•Medical Care•1995

  • Pharmacy Costs Groups

    Leida M Lamers•Medical Care•1999

Obras citantes distintas4
Citas por año0,24
Intervalo de citas2009 - 2017 (9)
Velocidad de citaciónhistorical
Altamente citadoNo
Tipos de citaNeutras: 3
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae